Andrea Necchi
@AndreaNecchi
Associate Professor @MyUniSR - Head of Genitourinary Medical Oncology @SanRaffaeleMI - Vice President @GTumors
ID:547064288
http://www.andreanecchi.com 06-04-2012 19:53:04
2,2K Tweets
3,2K Followers
1,0K Following
📝 Another negative trial of an FGFR inhibitor in later line UC: Derazantinib +/- atezo in metastatic UC with activating FGFR aberrations | including a cohort of FGFRi post FGFRi ylt Ospedale San Raffaele Università Vita-Salute San Raffaele UroToday.com Patrizia Giannatempo academic.oup.com/jncics/article…
The case for centralization of care in penile cancer — respecting geographical needs Nature Reviews Urology Philippe spiess Global Society of Rare GU Tumors Giuseppe_Basile Karima Oualla, MD,MSc UroToday.com nature.com/articles/s4158…
Excited to share our new review paper on 'Immune-based Therapies for Penile Cancer,' a collaboration with experts from
Moffitt Cancer Center Ospedale San Raffaele BCMHouston! Chiara Mercinelli Andrea Necchi Philippe spiess jc Weill Cornell Medicine Pathology WCM Englander Institute for Precision Medicine authors.elsevier.com/a/1ixLWLO5gOiQF
A worthy read setting the stage on current level of knowledge on primary urethral cancer. Proud of Dr Garcia-Perdomo in leading this effort with more to come by the GSRGT to advance current knowledge and treatments Global Society of Rare GU Tumors Andrea Necchi bjui-journals.onlinelibrary.wiley.com/doi/10.1111/bj…
Very last day at #EAU24 with Rafael Sanchez-Salas delivering the Confederación Americana de Urología (CAU) lecture in #RCC in plenary session European Association of Urology (EAU)
#EAU24 SunRISe-1: BCG-unresp HR NMIBC receiving TAR-200 monoRx Andrea Necchi UroToday.com
📌n=53, n=30 for efficacy: CR 77% (10/11 responses ≥6 mos, 6/6 ≥12 mos)
📌mDOR: NR
📌54% Gr 1-2 AEs
Disease Characterization: MRI in evaluation after neoadjuvant chemotherapy. Presentation by Andrea Necchi Università Vita-Salute San Raffaele. #EAU24 written coverage by Rashid K. Sayyid University of Toronto on UroToday > bit.ly/3xkL34S European Association of Urology (EAU)
Delve into the role of MRI post-neoadjuvant chemotherapy with Andrea Necchi
at #EAU24 ! Looking forward to gaining valuable insights into optimizing evaluation strategies in urological oncology. Don't miss this session! European Association of Urology (EAU)
Our review on novel therapeutic approaches on #PSCC is finally out! It was a pleasure to co-lead this work with Houssein Safa, MD, with the invaluable guidance of jc Philippe spiess & Andrea Necchi
#GUoncology #rarecancer #penilecancer
doi.org/10.1080/146565…
Join us September 19-21, 2024 in Bern, Switzerland for the IBCN Annual Meeting. See below for an amazing lineup of topics and speakers!!! Abstract deadline May 31st!! Roland Seiler-Blarer Peter Black Tilman Todenhöfer Kent Mouw Lars Dyrskjøt
I know one journal that invites papers and rejects them. Do you know Antonio Cigliola 😂😂 Valentina Tateo Chiara Mercinelli can recommend it!
Updated #BladderCancer #ESMOGuideline 📢 A change to the SoC for 1st line therapy for 1st time in 40 years. Enfortumab vedotin + pembro (EVP) new SoC in 1st-line advanced #UrothelialCarcinoma . Nivolumab–cisplatin–gemcitabine or platinum ChT & maintenance avelumab alternatives if…
Delighted to share with the scientific community a critical article re-defining rare GU (and other) cancers as an initiative by the GSRGT Global Society of Rare GU Tumors Andrea Necchi World Health Organization (WHO) ASCO ESMO - Eur. Oncology sciencedirect.com/science/articl…
Master di I livello in Metodologia della Ricerca Clinica in Oncologia A.A. 23/24 Università Vita-Salute San Raffaele 10 giorni rimasti per l’iscrizione! Università Vita-Salute San Raffaele Ospedale San Raffaele unisr.it/offerta-format…
Incidence, risk factors, and temporal trends of penile cancer: a global population‐based study - Huang - 2024 - BJU International - Global Society of Rare GU Tumors bjui-journals.onlinelibrary.wiley.com/doi/10.1111/bj…
Happy Friday! Happy Chinese New Year! Happy to share that our final version of our paper Modern Pathology is now available online at the following link: sciencedirect.com/science/articl… Congrats to Dr. Posada, our former Brown Pathology and Laboratory Medicine fellow, and our spectacular international team
⭐️Best part of ASCO GU are our friends and colleagues. #Highlights #GU24
Yüksel Ürün Shilpa Gupta Toni Choueiri, MD Sumanta K. Pal, MD, FASCO Andrea Necchi Neeraj Agarwal, MD, FASCO Amanda Nizam, MD Albert Jang, MD Dr. Bishoy M. Faltas Tian Zhang, MD, MHS Cristiane D Bergerot Laura Bukavina David Braun Emre Yekedüz
🔍 New insights on FDG-PET for MIBC patients! This imaging tool, previously underutilized, now shows promise in selecting candidates for neoadjuvant therapies by predicting lymph node involvement!
Antonio Cigliola, MD, Andrea Necchi Ospedale San Raffaele
ASCO #GU24 OncoAlert…
